Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 20,049 results that match your search.20,049 results
  • Interview: James Rogan James Rogan, the new director of the USPTO, speaks to Sam Mamudi about being at the helm of one of the most influential IP organizations in the world at a time of enormous challenge and growth
  • Managing IP hosted forums on the Unitary Patent and UPC in San Jose and New York last month. Here are some of the takeaways for IP owners in the United States
  • In the latest international briefing for Greece, Manolis Metaxakis evaluates upcoming reforms to trade mark law in the country
  • To compensate patent owners for the time it takes to obtain regulatory and marketing approval for new drugs, the Australian Patents Act provides for patent term extensions of up to five years. However, in order to have an extension of term granted, a number of requirements need to be satisfied. One of these requirements is that a patent discloses and claims a pharmaceutical substance per se or a pharmaceutical substance produced by a process that involves the use of recombinant DNA technology.
  • Since November 1 2007, a change in the Belgian Patent Law has made the courts of the Chambers of Commerce (in the jurisdictions where there is a Court of Appeal) the competent courts to decide patent cases, instead of the courts of first instance. The aim was to centralise the patent cases in fewer courts, five in practice, to ensure that these cases would over time be treated by more experienced judges.
  • The state of Kentucky has moved to identify the owners of the 141 domains it seized in 2008
  • Having won the bid to host the FIFA World Cup 2018, Russia is likely to pass a specific law to protect sponsors from ambush marketing
  • The National Pharmaceutical Control Bureau (NPCB) in Malaysia ensures the quality, efficacy and safety of pharmaceuticals through the evaluation of technical data and laboratory test conducted during clinical trial. Upon fulfilment of all safety regulations, approval is given for marketing.
  • A recent decision by the Swiss Federal Supreme Court has ended a 12-year battle between LEGO System and Mega Brands over the validity of Lego's three-dimensional building block trade mark registrations in Switzerland. The Supreme Court has now confirmed the nullity of Lego's respective trade mark registrations on grounds of technical necessity of the registered building block shapes.
  • Business method patent owners were dealt a blow this week after the PTAB confirmed it will assume the “broadest reasonable interpretation” of a patent when considering if its claims are too far-reaching under new post-grant challenge proceedings